# CCHD PulseOx screening vs PneumoRecs VaxAdvisor

The clearest difference is rating: CCHD PulseOx screening at 5.0 against PneumoRecs VaxAdvisor's 3.4. CCHD PulseOx screening also leads on iOS requirement (12.0 vs 18.0). PneumoRecs VaxAdvisor's advantage is update cadence (every 3 months vs every 22 months) and ratings volume (60 vs 1). On price, ads, in-app purchases and monetization model there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

CCHD PulseOx screening holds the better App Store score, 5.0 against 3.4. That said, the two scores are not equally well evidenced: PneumoRecs VaxAdvisor has 60 ratings behind it against 1, so its average is the more settled of the two.

CCHD PulseOx screening ships an update every 22 months, PneumoRecs VaxAdvisor every 3 months. The most recent releases landed on November 1, 2026 and November 3, 2026 respectively.

## The numbers

| Metric | CCHD PulseOx screening | PneumoRecs VaxAdvisor |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[5.0 (1 ratings)](https://appshunter.io/ios/app/cchd-pulseox-screening/id567756249/reviews)** | [3.4 (60 ratings)](https://appshunter.io/ios/app/pneumorecs-vaxadvisor/id1440647099/reviews) |
| Number of ratings | 1 | **60** |
| Positive reviews | — | 26.9% of reviews |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 22 months | **Every 3 months** |
| Monetization | Free | Free |
| Size | 33 MB | 6 MB |
| Requires iOS | **12.0** | 18.0 |
| Devices | **iPhone, iPad, iPod** | iPhone, iPad |
| Age rating | 17+ | 17+ |
| Developer | [Children's Healthcare of Atlanta, Inc.](https://appshunter.io/developer/1034460531) | [Centers For Disease Control and Prevention](https://appshunter.io/developer/439259253) |

## What reviewers say

### CCHD PulseOx screening

[App page](https://appshunter.io/ios/app/cchd-pulseox-screening/id567756249)

This app assists healthcare professionals in performing pulse oximetry screenings for newborns to detect critical congenital heart defects. Developed by Children's Healthcare of Atlanta, its algorithm is endorsed by leading medical organizations.

**Highlights:** Pulse oximetry screening implementation, Congenital heart defect detection, Newborn nursery aid, Endorsed algorithm, Healthcare professional tool

**Features:** macOS Compatibility

**In-app purchases:** none


### PneumoRecs VaxAdvisor

[App page](https://appshunter.io/ios/app/pneumorecs-vaxadvisor/id1440647099)

This application offers personalized pneumococcal vaccination guidance based on patient age, vaccination history, and medical conditions. It aligns with the Advisory Committee on Immunization Practices' recommendations for U.S. immunization schedules.

**Highlights:** Patient-specific vaccination recommendations, Age-based guidance, Vaccination history tracking, Underlying medical condition prompts, U.S. immunization schedule compliance

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is CCHD PulseOx screening free?

CCHD PulseOx screening is free to download, with no in-app purchases.

### Is PneumoRecs VaxAdvisor free?

PneumoRecs VaxAdvisor is free to download, with no in-app purchases.

### Which has better reviews, CCHD PulseOx screening or PneumoRecs VaxAdvisor?

CCHD PulseOx screening is rated higher. CCHD PulseOx screening averages 5.0 out of 5 from 1 ratings, while PneumoRecs VaxAdvisor averages 3.4 from 60 ratings.

### Do CCHD PulseOx screening or PneumoRecs VaxAdvisor have ads?

Neither CCHD PulseOx screening nor PneumoRecs VaxAdvisor shows ads.

### Which is updated more often, CCHD PulseOx screening or PneumoRecs VaxAdvisor?

CCHD PulseOx screening ships an update every 22 months, and PneumoRecs VaxAdvisor every 3 months. Most recently, CCHD PulseOx screening was updated on November 1, 2026 and PneumoRecs VaxAdvisor on November 3, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*